---
title: "Shanghai RAAS's controlling shareholder Haiyingkang has completed an increase in holdings, with a total investment amount of approximately 500 million yuan"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/257330992.md"
description: "According to the Zhitong Finance APP, Shanghai RAAS announced that its controlling shareholder Haiyingkang has completed the plan to increase its shareholding in the company. Haiyingkang has cumulatively increased its shareholding by 72.9353 million shares through centralized bidding on the Shenzhen Stock Exchange, accounting for 1.10% of the company's total share capital, with a total investment amount of approximately 500 million yuan (excluding transaction fees)"
datetime: "2025-09-15T09:31:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257330992.md)
  - [en](https://longbridge.com/en/news/257330992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257330992.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/257330992.md) | [English](https://longbridge.com/en/news/257330992.md)


# Shanghai RAAS's controlling shareholder Haiyingkang has completed an increase in holdings, with a total investment amount of approximately 500 million yuan

According to the Zhitong Finance APP, Shanghai RAAS (002252.SZ) announced that its controlling shareholder Haiyingkang has completed the plan to increase its shareholding in the company. Haiyingkang has cumulatively increased its shareholding by 72.9353 million shares through the Shenzhen Stock Exchange's centralized bidding method, accounting for 1.10% of the company's total share capital, with a total investment amount of approximately 500 million yuan (excluding transaction fees)

### 相關股票

- [Shanghai RAAS (002252.CN)](https://longbridge.com/zh-HK/quote/002252.CN.md)

## 相關資訊與研究

- [RAAS Blood Products Gets Plasma Collection License for Fengzhen Tonglu Plasma Collection Station](https://longbridge.com/zh-HK/news/278489427.md)
- [China Medical System says China approves Desidustat tablets for CKD anaemia](https://longbridge.com/zh-HK/news/279028848.md)
- [15:05 ETPreeclampsia Foundation Announces Major Maternal Health Initiative at HHS National Conference on Women's Health](https://longbridge.com/zh-HK/news/278930854.md)
- [The Naderi Center Introduces Advanced PRF Injections Using the EZPRF Platform](https://longbridge.com/zh-HK/news/278879007.md)
- [11:41 ETNovafjord Expands Multi-Asset Trading Services With AI-Driven Arbitrage and Risk Management Tools](https://longbridge.com/zh-HK/news/278417992.md)